If metformin is contraindicated or not tolerated, offer: an SGLT-2 inhibitor, and subcutaneous semaglutide (Ozempic), up to 1 mg once a week, for its cardiovascular, renal and glycaemic benefits (4) People with early onset type 2 diabetes (diabetes that has been diagnosed before the age of 40) For adults with early onset type 2 diabetes, offer modified-release metformin and an SGLT-2 inhibitor, and consider adding either: a GLP-1 receptor agonist for its cardiovascular, renal and glycaemic benefits or tirzepatide for its glycaemic benefits
How Weight Loss Changes the Equation When patients lose weight on GLP-1 medications, the reduction in plantar fascia load is immediate and proportional
Purchasing regulated cosmetics, and pharmaceuticals online can potentially pose serious health risks to the consumer
Individual responses vary significantly based on dose level, how long you've been on semaglutide, food intake, and personal metabolism